Had a chance to give it a good listen. He does me
Post# of 1418
(Total Views: 235)
Posted On: 04/28/2022 2:28:00 PM
Had a chance to give it a good listen. He does mentioning spinning off 3CL a couple times, although I didn't get the sense that it's imminent, just part of the plan.
However, in the Q&A he said that the ph2/3 tollovir trial would be funded by the spin-off, but if they are no longer part of todos, then how would todos have any involvement (other than a royalty). So, my thinking is that Todos keeps their share and then 3CL's portion is 'bought' by someone else, providing funding for continued work. I certainly like this plan better than the entire company going elsewhere....
However, in the Q&A he said that the ph2/3 tollovir trial would be funded by the spin-off, but if they are no longer part of todos, then how would todos have any involvement (other than a royalty). So, my thinking is that Todos keeps their share and then 3CL's portion is 'bought' by someone else, providing funding for continued work. I certainly like this plan better than the entire company going elsewhere....
(0)
(0)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼